Asia Business Gazette
SEE OTHER BRANDS

Fresh news on business and economy in Asia and the Pacific

Asia Business Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Business Gazette.

Press releases published on April 23, 2025

MARA Schedules Conference Call for First Quarter 2025 Financial Results

MARA Schedules Conference Call for First Quarter 2025 Financial Results

Earnings Webcast and Conference Call Set for Thursday, May 8, 2025 at 5:00 p.m. ET Fort Lauderdale, FL, April 23, 2025 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) ("MARA" or the "Company"), a global leader in leveraging digital asset compute to …

Highwoods Declares Quarterly Dividends

Highwoods Declares Quarterly Dividends

RALEIGH, N.C., April 23, 2025 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE:HIW) announces its Board of Directors has declared a cash dividend of $0.50 per share of common stock for the quarter ended March 31, 2025, which equates to an annualized …

Jewett-Cameron Expands Operational Efficiency Efforts

Jewett-Cameron Expands Operational Efficiency Efforts

NORTH PLAINS, Ore., April 23, 2025 (GLOBE NEWSWIRE) -- Jewett-Cameron Trading Company Ltd. (Nasdaq: JCTC), a company committed to innovative products that enrich outdoor spaces, today announced continued progress in its operational efficiency efforts …

Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025

Candel Therapeutics Announces Oral Presentation of Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025

NEEDHAM, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

Year-over-year revenue grows 8%, operating profit up 14%, non-GAAP operating profit up 13% Operating cash flow of $579 million Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, …

Horizon Bancorp, Inc. Reports First Quarter 2025 Results

Horizon Bancorp, Inc. Reports First Quarter 2025 Results

MICHIGAN CITY, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- (NASDAQ GS: HBNC) – Horizon Bancorp, Inc. (“Horizon” or the “Company”), the parent company of Horizon Bank (the “Bank”), announced its unaudited financial results for the three months ended March 31, …

Reliance, Inc. Reports First Quarter 2025 Financial Results

Reliance, Inc. Reports First Quarter 2025 Financial Results

-- Net sales of $3.48 billion with record tons sold, up 9.0% year-over-year (same-store tons sold up 5.6%)  -- Strong gross profit margin of 29.7%  -- EPS of $3.74; non-GAAP EPS of $3.77  -- Repurchased $253.2 million of common stock SCOTTSDALE, Ariz., …

Aerospace Design & Compliance Receives FAA PMA Certification, Expands In-House Manufacturing Capabilities

Aerospace Design & Compliance Receives FAA PMA Certification, Expands In-House Manufacturing Capabilities

Pompano Beach, FL , April 23, 2025 (GLOBE NEWSWIRE) -- Aerospace Design …

Vesper Holdings Expands its Student Housing Portfolio in Missouri with Acquisition of Brookside Downtown

Vesper Holdings Expands its Student Housing Portfolio in Missouri with Acquisition of Brookside Downtown

New York New York, April 23, 2025 (GLOBE NEWSWIRE) -- Vesper Holdings ("Vesper"), a privately-held real estate investment firm based in New York City, is pleased to announce its latest student housing acquisition – Brookside Downtown located near the …

Credit Acceptance Announces Timing of First Quarter 2025 Earnings Release and Webcast

Credit Acceptance Announces Timing of First Quarter 2025 Earnings Release and Webcast

Southfield, Michigan, April 23, 2025 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) announced today that we expect to issue a news release with our first quarter …

Credit Acceptance Recognized with Multiple 2025 Top Workplaces Spring Culture Excellence Awards

Credit Acceptance Recognized with Multiple 2025 Top Workplaces Spring Culture Excellence Awards

Southfield, Michigan, April 23, 2025 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) is proud to announce our recognition as a 2025 Spring Culture Excellence Top …

Goosehead Insurance, Inc. Announces First Quarter 2025 Results

Goosehead Insurance, Inc. Announces First Quarter 2025 Results

–   Total Revenue Increased 17% and Core Revenue* Grew 17% over the Prior-Year Period – –   Total Written Premium increased 22% to $1.0 billion over the Prior-Year Period – –   Net Income of $2.6 million versus Net Income of $1.8 million a year ago – –   …

EBC Financial Group : iFX EXPO 2025でLATAM市場での存在感や取引環境への貢献を強化

EBC Financial Group : iFX EXPO 2025でLATAM市場での存在感や取引環境への貢献を強化

EBC は、金融リテラシーからプラットフォームへのアクセスまで、急速に発展する LATAM の投資家環境に合わせたソリューションに焦点を当てています MEXICO, April 23, 2025 /⁨EINPresswire.com⁩/ -- EBC Financial Group(EBC)は、iFX EXPO LATAM 2025 …

Churchill Downs Incorporated Reports 2025 First Quarter Results

Churchill Downs Incorporated Reports 2025 First Quarter Results

LOUISVILLE, Ky., April 23, 2025 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (Nasdaq: CHDN) (the "Company", "CDI", "we") today reported business results for the first quarter ended March 31, 2025. Company Highlights First quarter 2025 financial results …

Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts

Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts

First U.S. patient dosed in ATALANTA-1 study of GLPG5101 Mantle cell lymphoma (MCL), a high-unmet-need hematological malignancy, selected as lead indication for the GLPG5101 program; Pivotal development planned to start in 2026 and aiming for approval in …

Galapagos rapporteert resultaten over het eerste kwartaal van 2025, recente hoogtepunten en verwachtingen op korte termijn

Galapagos rapporteert resultaten over het eerste kwartaal van 2025, recente hoogtepunten en verwachtingen op korte termijn

Eerste Amerikaanse patiënt gedoseerd in ATALANTA-1 studie met GLPG5101 Mantelcellymfoom (MCL), een hematologische maligniteit met een hoge onvervulde behoefte, geselecteerd als hoofdindicatie voor het GLPG5101-programma; pivotale ontwikkeling gepland voor …

Verses AI Inc. Announces Proposed Public Offering of Securities

Verses AI Inc. Announces Proposed Public Offering of Securities

VANCOUVER, British Columbia, April 23, 2025 (GLOBE NEWSWIRE) -- Verses AI Inc. (CBOE: VERS)(OTCQB: VRSSD) (“Verses” or the “Company”) is pleased to announce an offering (the “Offering”) of securities in Canada under the base shelf prospectus of the Company …

MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

MANH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Manhattan Associates, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

MANH INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Manhattan Associates, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz …

ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service